Extended Data Fig. 2: Qualitative RoI-level assessment of HistoPlexer.
From: Histopathology-based protein multiplex generation using deep learning
H&E (first column) and expression profiles of individual markers: S100, HLA-DR, HLA-ABC, gp100 and CD31 (from second to last column). Top row: ground-truth (GT) expression profiles; bottom row: predicted (pred) expression profiles.
